Search by Drug Name, NDC or Jcode
Internal Navigation
HCPCS Details
| HCPC | J0593 |
| Short Description | Inj., lanadelumab-flyo, 1 mg |
| Long Description | Injection, lanadelumab-flyo, 1 mg (code may be used for medicare when drug administered under direct supervision of a physician, not for use when drug is self-administered) |
| Pricing indicator | 51 |
| Coverage code | C |
| ASC payment group code | |
| BETOS2 code | O1E |
| Action code | P |
| Type of service | 1 |
| Effective date | 2024-01-01 |
| Date Added | 2019-10-01 |
Drug Details
-
Lanadelumab-flyo injection is used to prevent swelling and painful attacks of hereditary angioedema (HAE; an inherited condition that causes episodes of swelling in the hands, feet, face, airway, or intestines) in adults and children 2 years of age or older. Lanadelumab-flyo is in a class of medications called monoclonal antibodies. It works by blocking the action of a certain natural substance in the body that causes swelling and pain associated with HAE.